[Early phase II study of KRN8602 (MX2), a novel anthracycline derivative for acute leukemia]. [electronic resource]
Producer: 19990114Description: 2243-8 p. digitalISSN:- 0385-0684
- Adult
- Aged
- Anorexia -- chemically induced
- Antibiotics, Antineoplastic -- adverse effects
- Carubicin -- adverse effects
- Drug Administration Schedule
- Female
- Humans
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Middle Aged
- Nausea -- chemically induced
- Precursor Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; English Abstract; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.